Article

AAO 2019 Retina Street Team: John T. Thompson, MD

Author(s):

AAO 2019 Retina Street Team

John T. Thompson, MD, discusses retinal relativity and reimbursement roulette during Day 2 of the 2019 American Academy of Ophthalmology's annual meeting.

Read and watch more AAO 2019 Retina Street Team content.

Related Videos
Adam Wenick, MD, chairs EyeCon session: New treatments in geographic atrophy from detection to intervention
David Eichenbaum, MD, presents advances in AMD therapy, highlights different mechanisms with a common goal
Related Content
EyePoint Pharmaceuticals announces first patient dosed in global Phase 3 LUGANO clinical trial of Duravyu for wet AMD
October 24th 2024

EyePoint Pharmaceuticals announces first patient dosed in global Phase 3 LUGANO clinical trial of Duravyu for wet AMD

Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics
August 30th 2024

Latest advances in X-linked retinitis pigmentosa: Optimizing diagnosis and developments in gene therapy

Real-world evidence on latest retinal disease therapies
October 23rd 2024

Real-world evidence on latest retinal disease therapies

Assessing the Evidence for Extending Treatment Intervals in nAMD & DME Management: Expert Insights into Innovative Approaches
June 20th 2024

Assessing the Evidence for Extending Treatment Intervals in nAMD & DME Management: Expert Insights into Innovative Approaches

Inherited retinal diseases meet their therapeutic match
October 22nd 2024

Inherited retinal diseases meet their therapeutic match

AAO 2024: New drug shows promise as first to protect vision in patients with dry AMD
October 21st 2024

AAO 2024: New drug shows promise as first to protect vision in patients with dry AMD

© 2024 MJH Life Sciences

All rights reserved.